Ville Rauma1, Harri Sintonen2, Jari V Räsänen1, Jarmo A Salo1, Ilkka K Ilonen3. 1. Department of General Thoracic and Esophageal Surgery, Heart and Lung Center, Helsinki University Central Hospital, Helsinki, Finland. 2. Department of Public Health, Helsinki University, Faculty of Medicine, Helsinki, Finland. 3. Department of General Thoracic and Esophageal Surgery, Heart and Lung Center, Helsinki University Central Hospital, Helsinki, Finland. Electronic address: ilkka.ilonen@hus.fi.
Abstract
BACKGROUND: Retrospective evaluation of the long-term health-related quality of life (HRQoL) among survivors after non-small-cell lung cancer (NSCLC) surgery. PATIENTS AND METHODS: A total of 586 patients underwent surgery for NSCLC in Helsinki University Central Hospital between January 2000 and June 2009. Two validated quality-of-life questionnaires, the 15D and the EORTC QLQ-C30 with its lung cancer-specific module, QLQ-LC13, were sent to the 276 patients alive in June 2011. Response rate was 83.3%. Results of the 15D were compared with those of an age- and gender-standardized general population. RESULTS: Median follow-up was 5 years. Compared with a general population, our patients had a significantly lower 15D total score, representing their total HRQoL and scores for dimensions of mobility, breathing, usual activities, depression, distress, and vitality. The patients, however, scored significantly higher on vision, hearing, and mental function. CONCLUSIONS: NSCLC survivors may suffer postoperatively from permanently reduced long-term HRQoL compared to an age- and gender-matched general population. This is essential patient information as more patients are surviving longer.
BACKGROUND: Retrospective evaluation of the long-term health-related quality of life (HRQoL) among survivors after non-small-cell lung cancer (NSCLC) surgery. PATIENTS AND METHODS: A total of 586 patients underwent surgery for NSCLC in Helsinki University Central Hospital between January 2000 and June 2009. Two validated quality-of-life questionnaires, the 15D and the EORTC QLQ-C30 with its lung cancer-specific module, QLQ-LC13, were sent to the 276 patients alive in June 2011. Response rate was 83.3%. Results of the 15D were compared with those of an age- and gender-standardized general population. RESULTS: Median follow-up was 5 years. Compared with a general population, our patients had a significantly lower 15D total score, representing their total HRQoL and scores for dimensions of mobility, breathing, usual activities, depression, distress, and vitality. The patients, however, scored significantly higher on vision, hearing, and mental function. CONCLUSIONS:NSCLC survivors may suffer postoperatively from permanently reduced long-term HRQoL compared to an age- and gender-matched general population. This is essential patient information as more patients are surviving longer.
Authors: Yuhree Kim; Megan Winner; Andrew Page; Diana M Tisnado; Kathryn A Martinez; Stefan Buettner; Aslam Ejaz; Gaya Spolverato; Sydney E Morss Dy; Timothy M Pawlik Journal: Cancer Date: 2015-06-19 Impact factor: 6.860
Authors: Virginia Sun; Dan J Raz; Nora Ruel; Walter Chang; Loretta Erhunmwunsee; Karen Reckamp; Brian Tiep; Betty Ferrell; Ruth McCorkle; Jae Y Kim Journal: Clin Lung Cancer Date: 2017-02-02 Impact factor: 4.785
Authors: Virginia Sun; Jae Y Kim; Dan J Raz; Walter Chang; Loretta Erhunmwunsee; Carolina Uranga; Anne Marie Ireland; Karen Reckamp; Brian Tiep; Jennifer Hayter; Michael Lew; Betty Ferrell; Ruth McCorkle Journal: J Cancer Educ Date: 2018-06 Impact factor: 2.037